Giovanni Di Napoli

Giovanni Di Napoli is the CEO of Cosmo, an Irish pharmaceutical company listed on the Swiss stock exchange. Appointed in May 2024, he has since been at the forefront of the development of a new hair growth treatment featuring the active ingredient Clascoterone. Under his leadership, Cosmo has gained significant attention following promising preliminary study results, leading to a surge in interest from both potential customers and investors. Di Napoli is based in Lugano, Switzerland, but works primarily from the company's production facilities near Milan. As he navigates the high expectations surrounding the new product, he emphasizes that Cosmo is not solely defined by Clascoterone, boasting a diverse portfolio that could triple revenues by 2030.